These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29538364)

  • 1. Quantitative magnetic resonance imaging assessments of autosomal recessive polycystic kidney disease progression and response to therapy in an animal model.
    Erokwu BO; Anderson CE; Flask CA; Dell KM
    Pediatr Res; 2018 May; 83(5):1067-1074. PubMed ID: 29538364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-parametric MRI of kidney disease progression for autosomal recessive polycystic kidney disease: mouse model and initial patient results.
    MacAskill CJ; Erokwu BO; Markley M; Parsons A; Farr S; Zhang Y; Tran U; Chen Y; Anderson CE; Serai S; Hartung EA; Wessely O; Ma D; Dell KM; Flask CA
    Pediatr Res; 2021 Jan; 89(1):157-162. PubMed ID: 32283547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphate.
    Masyuk TV; Masyuk AI; Torres VE; Harris PC; Larusso NF
    Gastroenterology; 2007 Mar; 132(3):1104-16. PubMed ID: 17383431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial evaluation of hepatic T1 relaxation time as an imaging marker of liver disease associated with autosomal recessive polycystic kidney disease (ARPKD).
    Gao Y; Erokwu BO; DeSantis DA; Croniger CM; Schur RM; Lu L; Mariappuram J; Dell KM; Flask CA
    NMR Biomed; 2016 Jan; 29(1):84-9. PubMed ID: 26608869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy and processing time of kidney volume measurement methods in rodents polycystic kidney disease models: superiority of semiautomated kidney segmentation.
    Doss MC; Mullen S; Roye R; Zhou J; Chumley P; Mrug E; Wallace DP; Qian F; Harris PC; Yoder BK; Kim H; Mrug M
    Am J Physiol Renal Physiol; 2023 Apr; 324(4):F423-F430. PubMed ID: 36794756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telmisartan ameliorates fibrocystic liver disease in an orthologous rat model of human autosomal recessive polycystic kidney disease.
    Yoshihara D; Kugita M; Sasaki M; Horie S; Nakanishi K; Abe T; Aukema HM; Yamaguchi T; Nagao S
    PLoS One; 2013; 8(12):e81480. PubMed ID: 24324698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease stage characterization of hepatorenal fibrocystic pathology in the PCK rat model of ARPKD.
    Mason SB; Liang Y; Sinders RM; Miller CA; Eggleston-Gulyas T; Crisler-Roberts R; Harris PC; Gattone VH
    Anat Rec (Hoboken); 2010 Aug; 293(8):1279-88. PubMed ID: 20665806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Trpv4 reduces the hyperproliferative phenotype of cystic cholangiocytes from an animal model of ARPKD.
    Gradilone SA; Masyuk TV; Huang BQ; Banales JM; Lehmann GL; Radtke BN; Stroope A; Masyuk AI; Splinter PL; LaRusso NF
    Gastroenterology; 2010 Jul; 139(1):304-14.e2. PubMed ID: 20399209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Empirical Biomarker-Based Calculator for Cystic Index in a Model of Autosomal Recessive Polycystic Kidney Disease-The Nieto-Narayan Formula.
    Nieto JA; Yamin MA; Goldberg ID; Narayan P
    PLoS One; 2016; 11(10):e0163063. PubMed ID: 27695033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease.
    Torres VE; King BF; Chapman AB; Brummer ME; Bae KT; Glockner JF; Arya K; Risk D; Felmlee JP; Grantham JJ; Guay-Woodford LM; Bennett WM; Klahr S; Meyers CM; Zhang X; Thompson PA; Miller JP;
    Clin J Am Soc Nephrol; 2007 Jan; 2(1):112-20. PubMed ID: 17699395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Resolution Ultrasonography for Assessment of Renal Cysts in the PCK Rat Model of Autosomal Recessive Polycystic Kidney Disease.
    Kapoor S; Rodriguez D; Mitchell K; Wüthrich RP
    Kidney Blood Press Res; 2016; 41(2):186-96. PubMed ID: 26981631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-type natriuretic peptide overexpression ameliorates hepatorenal fibrocystic disease in a rat model of polycystic kidney disease.
    Holditch SJ; Schreiber CA; Harris PC; LaRusso NF; Ramirez-Alvarado M; Cataliotti A; Torres VE; Ikeda Y
    Kidney Int; 2017 Sep; 92(3):657-668. PubMed ID: 28416225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPAR-gamma agonist ameliorates kidney and liver disease in an orthologous rat model of human autosomal recessive polycystic kidney disease.
    Yoshihara D; Kurahashi H; Morita M; Kugita M; Hiki Y; Aukema HM; Yamaguchi T; Calvet JP; Wallace DP; Nagao S
    Am J Physiol Renal Physiol; 2011 Feb; 300(2):F465-74. PubMed ID: 21147840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of purinergic receptor expression in ARPKD cystic epithelia.
    Palygin O; Ilatovskaya DV; Levchenko V; Klemens CA; Dissanayake L; Williams AM; Pavlov TS; Staruschenko A
    Purinergic Signal; 2018 Dec; 14(4):485-497. PubMed ID: 30417216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Looking at the (w)hole: magnet resonance imaging in polycystic kidney disease.
    Liebau MC; Serra AL
    Pediatr Nephrol; 2013 Sep; 28(9):1771-83. PubMed ID: 23239392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Mast Cell Degranulation With Cromolyn Sodium Exhibits Organ-Specific Effects in Polycystic Kidney (PCK) Rats.
    Jiang L; Fang P; Septer S; Apte U; Pritchard MT
    Int J Toxicol; 2018; 37(4):308-326. PubMed ID: 29862868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of progression in autosomal dominant and autosomal recessive polycystic kidney disease.
    Benz EG; Hartung EA
    Pediatr Nephrol; 2021 Sep; 36(9):2639-2658. PubMed ID: 33474686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of P2X
    Xu B; Nikolaienko O; Levchenko V; Choubey AS; Isaeva E; Staruschenko A; Palygin O
    Physiol Rep; 2022 Nov; 10(21):e15510. PubMed ID: 36353932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging of fetal autosomal recessive polycystic kidney disease.
    Nasu K; Yoshimatsu J; Anai T; Miyakawa I; Komatsu E; Maeda T
    J Obstet Gynaecol Res; 1998 Feb; 24(1):33-6. PubMed ID: 9564103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic blockade of 20-HETE synthesis reduces polycystic kidney disease in an orthologous rat model of ARPKD.
    Park F; Sweeney WE; Jia G; Akbulut T; Mueller B; Falck JR; Birudaraju S; Roman RJ; Avner ED
    Am J Physiol Renal Physiol; 2009 Mar; 296(3):F575-82. PubMed ID: 19129252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.